Trial Profile
Phase I multiple-dose study of TC 5619.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2011
Price :
$35
*
At a glance
- Drugs Bradanicline (Primary)
- Indications Cognition disorders
- Focus Adverse reactions
- 03 May 2011 Status changed from planning to completed.
- 16 May 2008 New trial record.